The main focus is on:
Finance & Investment: Access investment advice and partnership opportunities through the Investor Forum
Scalable Manufacturing: Identify best practices in technology and latest updates from biotechs, through interactive roundtables
Translational Medicine: Discover how best to gain market access for cell therapies
Tissue Engineering: Hear pioneering innovations in tissue engineering as well as organ regeneration and 3D bioprinting
Commercialisation: Understand how industry leaders view the clinical and commercial futures of stem cells and regenerative medicine and the effect it will have on your business
Can you help advance cell therapy and regenerative medicine programs?
If so, we have an audience of stem cell entrepreneurs, innovators and disruptors looking to move their business forward.
At last years World Drug Safety Congress Europe 2014 event, Anca Miclea, Senior Specialist Medical Safety and Epidemiology Global Pharmacovigilance, Abbott laboratories, gave the presentation ...
The post Safety, pharmacoepidemiology and research in practice: assessment of causation appeared first on Total Biopharma.
Remsima Case Study: The importance of ADCC in assessing clinically relevant differences Authors: Dr. Daniel Galbraith, Chief Scientific Officer and Andy Upsall, Director of Technical ...
The post Biosimilars have caused a revolution in the development of biologic drugs appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D